MedTrace Logo

Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"

NCT04776642 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-01-25

No results posted yet for this study

Summary

The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis.

Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

Conditions

  • Arrythmia
  • Conduction Disorder
  • Pathophysiology

Interventions

OTHER

Biobank for Left atrial appendage tissue

Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

OTHER

Biobank for Blood

Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

OTHER

Biobank for One or more of following fat patches: epicardial fat, subcutaneous fat, pericardial fat, visceral fat.

Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Joris de Groot, MD, PhD · Amsterdam UMC - AMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-18
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776642 on ClinicalTrials.gov